Logo of Servier Pharmaceuticals from LinkedIn
Jul 4, 2024, 16:15
POLARIS has been named a finalist for the Langland Award for Excellence in Healthcare Partnership
Servier Pharmaceuticals shared on LinkedIn:
“We are excited to announce that POLARIS, our innovative project to enhance communication for acute lymphoblastic leukaemia (ALL) treatment, has been named a finalist for the Langland Award for Excellence in Healthcare Partnership!
POLARIS was a collaborative development between Servier, SIOP Europe, CCI Europe, Syneos Health France and the Velella Group, that provides clear, accessible treatment roadmaps and personalized web-based support, helping families track treatments in real-time and in their native languages.
Thank you to our partners and to the Communique Awards for this recognition! We remain committed to empowering families and improving the ALL treatment journey.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 21, 2024, 06:49
Nov 20, 2024, 20:38
Nov 20, 2024, 20:27
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12